US Stock MarketDetailed Quotes

CGON CG Oncology

Watchlist
  • 28.450
  • -0.820-2.80%
Close Dec 18 16:00 ET
  • 29.800
  • +1.350+4.75%
Pre 06:32 ET
2.13BMarket Cap-24.53P/E (TTM)

About CG Oncology Company

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Irvine, CA.

Company Profile

SymbolCGON
Company NameCG Oncology
Listing DateJan 25, 2024
Issue Price19.00
Founded2010
CEOMr. Arthur Kuan
MarketNASDAQ
Employees61
Fiscal Year Ends12-31
Address400 Spectrum Center Drive,Suite 2040
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-949-409-3700
Websitehttp://www.cgoncology.com

Company Executives

  • Name
  • Position
  • Salary
  • Arthur Kuan
  • Chairman of the Board and Chief Executive Officer
  • 3.74M
  • Ambaw Bellete
  • President and Chief Operating Officer
  • 2.85M
  • Dr. Vijay Kasturi, M.D.
  • Chief Medical Officer
  • 2.36M
  • Corleen M. Roche
  • Chief Financial Officer and Secretary
  • --
  • Dr. James J. Mule
  • Independent Director
  • 198.00K
  • Dr. Brian Liu, M.D.
  • Independent Director
  • --
  • Susan E. Graf
  • Independent Director
  • 599.04K
  • Hong Fang Song
  • Independent Director
  • --
  • Dr. Leonard E. Post, PhD
  • Lead Independent Director
  • 77.54K
  • Victor Tong, Jr
  • Independent Director
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Apple
AAPL
-2.14%
Oracle
ORCL
-2.53%
Adobe
ADBE
-3.06%
Ecopetrol
EC
-3.17%
D.R. Horton
DHI
-3.37%

Unlock the Full List